Curis Inc SEC filings CRIS
Curis Inc has 1,006 filings in SEC EDGAR's recent list, going back to Jun 3, 2005. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B4 | Prospectus | Aug 13, 2026 | — |
| S-1 | Registration statement | Aug 10, 2026 | — |
| S-3 | Shelf registration | Feb 13, 2026 | — |
| S-8 | Employee stock plan registration | Nov 6, 2025 | — |
| S-1 | Registration statement | Aug 11, 2025 | — |
| 424B5 | Prospectus supplement | Aug 8, 2025 | — |
| 424B5 | Prospectus supplement | Jul 2, 2025 | — |
| FWP | Free writing prospectus | Jul 2, 2025 | — |
| S-3 | Shelf registration | May 7, 2025 | — |
| 424B5 | Prospectus supplement | Mar 31, 2025 | — |
| FWP | Free writing prospectus | Mar 31, 2025 | — |
| S-3 | Shelf registration | Dec 23, 2024 | — |
| 424B5 | Prospectus supplement | Oct 30, 2024 | — |
| FWP | Free writing prospectus | Oct 29, 2024 | — |
| S-8 | Employee stock plan registration | Jun 14, 2024 | — |
| S-8 | Employee stock plan registration | Feb 8, 2024 | — |
| S-3 | Shelf registration | Feb 8, 2024 | — |
| 424B5 | Prospectus supplement | Jul 6, 2023 | — |
| S-8 | Employee stock plan registration | Oct 7, 2022 | — |
| POS AM | Filing | Feb 24, 2022 | — |
| S-8 | Employee stock plan registration | Oct 15, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 16, 2021 | — |
| 424B5 | Prospectus supplement | Dec 10, 2020 | — |
| S-3MEF | Filing | Dec 9, 2020 | — |
| 424B5 | Prospectus supplement | Dec 9, 2020 | — |
| S-8 | Employee stock plan registration | Dec 4, 2020 | — |
| 424B5 | Prospectus supplement | Jun 12, 2020 | — |
| 424B5 | Prospectus supplement | Mar 6, 2020 | — |
| 424B5 | Prospectus supplement | Mar 6, 2020 | — |
| 424B5 | Prospectus supplement | Feb 27, 2020 | — |
| S-8 | Employee stock plan registration | Dec 13, 2019 | — |
| S-8 | Employee stock plan registration | Dec 14, 2018 | — |
| S-3 | Shelf registration | May 3, 2018 | — |
| S-8 | Employee stock plan registration | Dec 22, 2017 | — |
| 424B5 | Prospectus supplement | Sep 15, 2017 | — |
| 424B5 | Prospectus supplement | Sep 13, 2017 | — |
| S-8 | Employee stock plan registration | Jun 9, 2017 | — |
| S-8 | Employee stock plan registration | Jan 6, 2017 | — |
| S-3 | Shelf registration | Dec 5, 2016 | — |
| S-3/A | Filing | Aug 28, 2015 | — |
| S-8 | Employee stock plan registration | Aug 12, 2015 | — |
| S-3 | Shelf registration | Jul 2, 2015 | — |
| S-3 | Shelf registration | Apr 17, 2015 | — |
| 424B5 | Prospectus supplement | Feb 25, 2015 | — |
| 424B5 | Prospectus supplement | Feb 24, 2015 | — |
| S-8 | Employee stock plan registration | Sep 10, 2013 | — |
| S-3 | Shelf registration | Jul 3, 2013 | — |
| 424B5 | Prospectus supplement | Jun 13, 2011 | — |
| S-3 | Shelf registration | Dec 23, 2010 | — |
| S-8 | Employee stock plan registration | Jun 22, 2010 | — |
| 424B5 | Prospectus supplement | Jan 22, 2010 | — |
| S-8 | Employee stock plan registration | Feb 26, 2009 | — |
| S-3 | Shelf registration | Jul 29, 2008 | — |
| S-8 | Employee stock plan registration | Mar 14, 2008 | — |
| S-3 | Shelf registration | Aug 24, 2007 | — |
| S-8 | Employee stock plan registration | Mar 9, 2007 | — |
| S-8 | Employee stock plan registration | Sep 15, 2006 | — |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRIS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1108205
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.